REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
November 3, 2026
FROM
ANDREW GOLDFRACH, ARMC Chief Executive Officer, Arrowhead Regional Medical Center
SUBJECT
Title
Amendment to Agreement with Baxter Healthcare Corporation for Software Licenses
End
RECOMMENDATION(S)
Recommendation
Approve Amendment No. 1 to Agreement No. 24-965 with Baxter Healthcare Corporation, to be used to formulate intravenous nutrition solutions, adding installation support, validation and testing for Abacus software compatibility with a Windows 11 networked workstation, increasing the total contract amount by $600, from $75,843.60 to $76,443.60, with no change to the original five-year period beginning on November 1, 2024 through October 31, 2029.
(Presenter: Andrew Goldfrach, ARMC Chief Executive Officer, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Operate in a Fiscally-Responsible and Business-Like Manner.
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of Discretionary General Funding (Net County Cost). The cost of $600 is funded by State Medi-Cal, federal Medicare, private insurance, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue have been included in the Arrowhead Regional Medical Center (ARMC) 2026-27 budget and will be included in future recommended budgets.
BACKGROUND INFORMATION
The Amendment will allow ARMC to continue to utilize the Baxter Healthcare Corporation (Baxter) Exactamix Compounder (Compounder) equipment and Abacus software license for the accurate preparation of patient specific total parenteral nutrition (TPN). TPN is intravenous feeding formulations for both adult and neonatal patients. The Amendment is for services to install the Abacus software in a new Microsoft Windows 11 networked computer and ensure Windows 11 compatibility through validation and testing.
The Compounder and Abacus software enables the pharmacy to compound neonatal and adult parenteral solutions safely and efficiently. The Compounder mixes parental ingredients to formulate intravenous nutrition solutions that are tailored to the individual patient. The Abacus software, which is designed to work only with the Compounder, performs complex formulation calculations, provides clinically important ingredient compatibility and dose warnings to the pharmacist.
On October 8, 2024 (Item No. 11), the Board of Supervisors approved Agreement No. 24-965 with Baxter for the Exactamix Compounder Lease and Abacus Software License Healthcare Corporation, including non-standard terms, to be used to formulate intravenous nutrition solutions, in the amount of $75,843.60, for the agreement term of November 1, 2024, through October 31, 2029.
ARMC recommends approval of the Amendment to provide for the safety, health and social needs of the County residents by providing accurate and safe preparation of patient-specific TPN to improve patient outcomes and quality of life for County residents.
PROCUREMENT
Not applicable.
REVIEW BY OTHERS
This item has been reviewed by County Counsel (Bonnie Uphold, Supervising Deputy County Counsel, 387-5455) on October 22, 2026; Purchasing (Veronica Pedace, Buyer III, 387-2464) on October 6, 2026; ARMC Finance (Chen Wu, Finance and Budget Officer, 580-3165) on October 9, 2026; and County Finance and Administration (Jenny Yang, Administrative Analyst, 387-4884) on October 13, 2026.